Company / Income Tax
Arcus Biosciences, Inc. Income Tax History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-
FY2025
5-year range
$0 / $6.0M
FY2021-FY2025
Trend
-100.0%
vs FY2024
Sector context
#120 of 204
Health Care
What the data says
Improved from $6M to $0 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#85 of 204 in Health CareTop 41% of 204
▼
Key checks
Key Insights
- In FY2025, income tax decreased 100.0% year-over-year.
- Peak income tax was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $1.0M | -83.3% |
| FY2023 | $6.0M | +200.0% |
| FY2022 | $2.0M | +0.0% |
| FY2021 | $2.0M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026